{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T02:38:51Z","timestamp":1777775931398,"version":"3.51.4"},"reference-count":28,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Hyperuricemia is associated with an increased risk of cardio-and cerebrovascular disease (CVD) in general population. However, in the hemodialysis (HD) patients, low serum uric acid (SUA) increases the risk of mortality. Considering that CVD is the principal cause of death among maintenance HD patients, the present study aimed to determine the predictive value of SUA for CVD outcome in this population.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    In this two-year follow-up prospective study, 205 outpatients under maintenance HD were enrolled from March 2017 to 2020. Patients\u2019 demographic data, underlying diseases, and the results of serum tests, as well as two-year follow-up results of CVD events and mortality were recorded.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    A total of 130 (63%) patients were eligible for analysis; 62.9% were male; mean age of participants was 59\u00b113years. At follow-up, coronary artery disease was observed in 43.2%, peripheral artery disease in 26.5%, and cerebrovascular disease in 20.5%; angiography was required in 52.3% and 4.5% died of CVD. SUA was \u22645.4 mg\/dL in 52 patients, 5.5\u20136.1 mg\/dL in 19, and \u22656.2 mg\/dL in 59 patients with significant difference based on mean age, sex distribution, occurrence of cerebrovascular disease and cardiovascular mortality (P&lt;0.05). Patients with cerebrovascular disease had a significantly lower SUA levels (P=0.006). Logistic regression showed the significant effect of SUA on the occurrence of cerebrovascular disease (P=0.008).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Low SUA can predict two-year incidence of cerebrovascular disease in HD patients. However, SUA levels did not show significant predictive effect on two-year coronary events, peripheral artery disease and cardiovascular mortality.\n                  <\/jats:p>","DOI":"10.2478\/rjim-2021-0039","type":"journal-article","created":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T09:55:50Z","timestamp":1641635750000},"page":"115-122","source":"Crossref","is-referenced-by-count":0,"title":["Serum uric acid as a predictor of cardio- and cerebro-vascular diseases in maintenance hemodialysis patients"],"prefix":"10.2478","volume":"60","author":[{"given":"Najmeh","family":"Khodabandeh","sequence":"first","affiliation":[{"name":"Resident of Internal Medicine, Clinical Research Development Unit of Shohada Tajrish Hospital , Shahid Beheshti University of Medical Science , Tehran , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elahe","family":"Taziki","sequence":"additional","affiliation":[{"name":"Associated professor of nephrology. Shohada Tajrish Hospital , Shahid Beheshti University of Medical Science , Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toktam","family":"Alirezaei","sequence":"additional","affiliation":[{"name":"Associated professor of cardiology. Clinical Research Development Unit of Shohada Tajrish Hospital , Shahid Beheshti University of Medical Science , Tehran , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"2026042914151565202_j_rjim-2021-0039_ref_001","doi-asserted-by":"crossref","unstructured":"1. JHA V, GARCIA-GARCIA G, ISEKI K, LI Z, NAICKER S, PLATTNER B, et al. Chronic kidney disease: global dimension and perspectives. The Lancet. 2013;382(9888):260\u201372.10.1016\/S0140-6736(13)60687-X","DOI":"10.1016\/S0140-6736(13)60687-X"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_002","unstructured":"2. CLARKSON KA, ROBINSON K. Life on dialysis: a lived experience. Nephrol Nurs J. 2010;37(1):29\u201335."},{"key":"2026042914151565202_j_rjim-2021-0039_ref_003","doi-asserted-by":"crossref","unstructured":"3. CHUASUWAN A, POORIPUSSARAKUL S, THAKKINSTIAN A, INGSATHIT A, PATTANAPRATEEP O. Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: a systematic review and meta-analysis. Health Qual. life outcomes. 2020;18(1):1\u201311.10.1186\/s12955-020-01449-2","DOI":"10.1186\/s12955-020-01449-2"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_004","doi-asserted-by":"crossref","unstructured":"4. MOUSAVI SSB, SOLEIMANI A, MOUSAVI MB. Epidemiology of end-stage renal disease in Iran: a review article. Saudi J Kidney Dis Transpl. 2014;25(3):697\u2013702.10.4103\/1319-2442.13224224821181","DOI":"10.4103\/1319-2442.132242"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_005","unstructured":"5. BELADI-MOUSAVI SS, ALEMZADEH-ANSARI MJ, ALEMZADEH-ANSARI MH, BELADI-MOUSAVI M. Long-term survival of patients with end-stage renal disease on maintenance hemodialysis: a multicenter study in Iran. Iran J Kidney Dis. 2012;6(6):452\u201356."},{"key":"2026042914151565202_j_rjim-2021-0039_ref_006","doi-asserted-by":"crossref","unstructured":"6. COZZOLINO M, MANGANO M, STUCCHI A, CICERI P, CONTE F, GALASSI A. Cardiovascular disease in dialysis patients. Nephrol. Dial. Transplant. 2018;33(suppl_3): iii28\u2013iii34.10.1093\/ndt\/gfy174616881630281132","DOI":"10.1093\/ndt\/gfy174"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_007","doi-asserted-by":"crossref","unstructured":"7. COUSER WG, REMUZZI G, MENDIS S, TONELLI M. The contribution of chronic kidney disease to the global burden of major no communicable diseases. Kidney Int. 2011;80(12):1258\u201370.10.1038\/ki.2011.36821993585","DOI":"10.1038\/ki.2011.368"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_008","unstructured":"8. OSSAREH S, FARROKHI F, ZEBARJADI M. Survival of Patients on Hemodialysis and Predictors of Mortality: a Single-Centre Analysis of Time-Dependent Factors. Iran J Kidney Dis. 2016;10(6):369\u201380."},{"key":"2026042914151565202_j_rjim-2021-0039_ref_009","doi-asserted-by":"crossref","unstructured":"9. SOLTANI Z, RASHEED K, KAPUSTA DR, REISIN E. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr. Hypertens. Rep. 2013;15(3):175\u201381.10.1007\/s11906-013-0344-5","DOI":"10.1007\/s11906-013-0344-5"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_010","doi-asserted-by":"crossref","unstructured":"10. LATIF W, KARABOYAS A, TONG L, WINCHESTER JF, ARRINGTON CJ, PISONI RL, et al. Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population. Clin J Am Soc Nephrol. 2011;6(10):2470\u201377.10.2215\/CJN.00670111335956221868616","DOI":"10.2215\/CJN.00670111"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_011","doi-asserted-by":"crossref","unstructured":"11. KIM CS, JIN D-C, YUN YC, BAE EH, MA SK, KIM SW. Relationship between serum uric acid and mortality among hemodialysis patients: Retrospective analysis of Korean end-stage renal disease registry data. Kidney Res Clin Pract. 2017;36(4):368\u201376.10.23876\/j.krcp.2017.36.4.368574304629285429","DOI":"10.23876\/j.krcp.2017.36.4.368"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_012","doi-asserted-by":"crossref","unstructured":"12. PARK C, OBI Y, STREJA E, RHEE CM, CATABAY CJ, VAZIRI ND, et al. Serum uric acid, protein intake and mortality in hemodialysis patients. Nephrol Dial Transplant. 2017;32(10):1750\u201357.10.1093\/ndt\/gfw419583768728064158","DOI":"10.1093\/ndt\/gfw419"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_013","doi-asserted-by":"crossref","unstructured":"13. BEBERASHVILI I, ERLICH A, AZAR A, SINUANI I, FELDMAN L, GORELIK O, et al. Longitudinal study of serum uric acid, nutritional status, and mortality in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2016;11(6):1015\u201323.10.2215\/CJN.10400915489175327026520","DOI":"10.2215\/CJN.10400915"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_014","doi-asserted-by":"crossref","unstructured":"14. LOVRE D, SHAH S, SIHOTA A, FONSECA VA. Managing diabetes and cardiovascular risk in chronic kidney disease patients. Endocrinol Metab Clin. 2018;47(1):237\u201357.10.1016\/j.ecl.2017.10.006580613929407054","DOI":"10.1016\/j.ecl.2017.10.006"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_015","doi-asserted-by":"crossref","unstructured":"15. MURRAY T, GOLDBERG M. Chronic interstitial nephritis: etiologic factors. Ann Intern Med. 1975;82(4):453\u201355.10.7326\/0003-4819-82-4-4531119762","DOI":"10.7326\/0003-4819-82-4-453"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_016","doi-asserted-by":"crossref","unstructured":"16. BEBERASHVILI I, SINUANI I, AZAR A, SHAPIRO G, FELDMAN L, STAV K, et al. Serum uric acid as a clinically useful nutritional marker and predictor of outcome in maintenance hemodialysis patients. Nutr J. 2015;31(1):138\u201347.10.1016\/j.nut.2014.06.01225466658","DOI":"10.1016\/j.nut.2014.06.012"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_017","doi-asserted-by":"crossref","unstructured":"17. FIRTH D. Bias Reduction of Maximum Likelihood Estimates. Biometrika 1993; 80(1):27\u201338.10.1093\/biomet\/80.1.27","DOI":"10.1093\/biomet\/80.1.27"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_018","unstructured":"18. HEINZE G, PLONER M, DUNKLER D, SOUTHWORTH H, HEINZE MG. \u201cPackage \u2018logistf\u201d (2020)."},{"key":"2026042914151565202_j_rjim-2021-0039_ref_019","doi-asserted-by":"crossref","unstructured":"19. KUCIRKA LM, GRAMS ME, LESSLER J, HALL EC, JAMES N, MASSIE AB, et al. Association of race and age with survival among patients undergoing dialysis. JAMA. 2011;306(6):620\u201326.10.1001\/jama.2011.1127393809821828325","DOI":"10.1001\/jama.2011.1127"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_020","doi-asserted-by":"crossref","unstructured":"20. CHANDRASHEKAR A, RAMAKRISHNAN S, RANGARAJAN D. Survival analysis of patients on maintenance hemodialysis. Indian J Nephrol. 2014;24(4):206\u201313.10.4103\/0971-4065.132985411933225097332","DOI":"10.4103\/0971-4065.132985"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_021","doi-asserted-by":"crossref","unstructured":"21. ECKARDT K-U, KIM J, KRONENBERG F, ALJAMA P, ANKER SD, CANAUD B, et al. Hemoglobin variability does not predict mortality in European hemodialysis patients. J Am Soc Nephrol. 2010;21(10):1765\u201375.10.1681\/ASN.2009101017301353420798262","DOI":"10.1681\/ASN.2009101017"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_022","doi-asserted-by":"crossref","unstructured":"22. GOODKIN DA, FULLER DS, ROBINSON BM, COMBE C, FLUCK R, MENDELSSOHN D, et al. Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients. J Am Soc Nephrol. 2011;22(2):358\u201365.10.1681\/ASN.2010020173302990821164028","DOI":"10.1681\/ASN.2010020173"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_023","doi-asserted-by":"crossref","unstructured":"23. KREDIET RT, BALAFA O. Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol. 2010;6(8):451\u201360.10.1038\/nrneph.2010.6820567248","DOI":"10.1038\/nrneph.2010.68"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_024","doi-asserted-by":"crossref","unstructured":"24. CHANG TI, STREJA E, SOOHOO M, KIM TW, RHEE CM, KOVESDY CP, et al. Association of serum triglyceride to HDL cholesterol ratio with all-cause and cardiovascular mortality in incident hemodialysis patients. Clin J Am Soc Nephrol. 2017;12(4):591\u2013602.10.2215\/CJN.08730816538338828193609","DOI":"10.2215\/CJN.08730816"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_025","doi-asserted-by":"crossref","unstructured":"25. RAJU D, LALITHA D, KIRANMAYI P. A study of lipid profile and lipid peroxidation in chronic kidney disease with special reference to hemodialysis. J Clinic Res Bioeth. 2013;4(1):1\u20135.10.4172\/2155-9627.1000143","DOI":"10.4172\/2155-9627.1000143"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_026","doi-asserted-by":"crossref","unstructured":"26. MIKOLASEVIC I, \u017dUTELIJA M, MAVRINAC V, ORLIC L. Dyslipidemia in patients with chronic kidney disease: etiology and management. Int J Nephrol Renovasc dis. 2017; 10:35\u201345.10.2147\/IJNRD.S101808530497128223836","DOI":"10.2147\/IJNRD.S101808"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_027","doi-asserted-by":"crossref","unstructured":"27. ZHANG B, GAO C, YANG N, ZHANG W, SONG X, YIN J, et al. Is elevated SUA associated with a worse outcome in young Chinese patients with acute cerebral ischemic stroke? BMC Neurol. 2010;10(1):1\u20136.10.1186\/1471-2377-10-82294960820849639","DOI":"10.1186\/1471-2377-10-82"},{"key":"2026042914151565202_j_rjim-2021-0039_ref_028","doi-asserted-by":"crossref","unstructured":"28. CHIQUETE E, RUIZ-SANDOVAL JL, MURILLO-BONILLA LM, ARAUZ A, OROZCO-VALERA DR, OCHOA-GUZM\u00c1N A, et al. Serum uric acid and outcome after acute ischemic stroke: PREMIER study. Cerebrovasc Dis. 2013;35(2):168\u201374.10.1159\/00034660323446426","DOI":"10.1159\/000346603"}],"container-title":["Romanian Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/rjim-2021-0039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:19:11Z","timestamp":1777486751000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/rjim-2021-0039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,6,14]]},"published-print":{"date-parts":[[2022,6,1]]}},"alternative-id":["10.2478\/rjim-2021-0039"],"URL":"https:\/\/doi.org\/10.2478\/rjim-2021-0039","relation":{},"ISSN":["2501-062X"],"issn-type":[{"value":"2501-062X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}